Home/Pipeline/ENZYSYSTEM for Coagulation Monitoring

ENZYSYSTEM for Coagulation Monitoring

Hemophilia and other chronic bleeding disorders

DevelopmentActive

Key Facts

Indication
Hemophilia and other chronic bleeding disorders
Phase
Development
Status
Active
Company

About Enzyre

Enzyre is a private, pre-revenue diagnostics company developing a novel point-of-care platform for blood coagulation monitoring. Its ENZYSYSTEM integrates a proprietary chemiluminescent detection technology with a microfluidic cartridge and a handheld processor, aiming to deliver lab-quality multi-parameter coagulation tests outside the central lab. The company's initial focus is on improving the management of chronic bleeding disorders like hemophilia, with the goal of providing patients and physicians with immediate, actionable data to optimize therapy. Enzyre is supported by European grants and is positioning its platform for broader diagnostic applications through future collaborations.

View full company profile

Therapeutic Areas